ALTERTOX

Their core work

ALTERTOX is a Belgian SME specializing in alternative toxicology — replacing animal testing with mechanism-based, computational, and AI-driven methods for chemical safety assessment. They contribute expertise in adverse outcome pathways, systems toxicology, and next-generation risk assessment to large EU research consortia. Their work spans predicting chemical hazards without animal models, assessing risks from complex chemical mixtures, and building ontology-driven frameworks for repeated-dose toxicity testing.

What they specialise in

How they've shifted over time

All three ALTERTOX projects started in 2021, so the evolution window is narrow. However, keyword analysis shows a clear broadening: early keywords centered on foundational science (adverse outcome pathways, mechanistic toxicology, phylogenetic toxicology), while recent keywords expand into applied tools — AI, ontology, chemical hazard prediction, and mixture modelling. This suggests a shift from understanding toxicity mechanisms toward building practical, computational tools for regulatory-ready chemical safety assessment.

ALTERTOX is moving from fundamental toxicology science toward AI-powered, regulatory-applicable tools for chemical risk assessment — making them increasingly relevant as the EU tightens chemical safety regulations.

How they like to work

ALTERTOX operates exclusively as a participant, never coordinating — typical for a specialized SME that contributes deep domain expertise rather than managing large consortia. With 43 unique partners across 13 countries from just 3 projects, they work in large, well-funded Research and Innovation Actions (average consortium of ~14 partners). This makes them an accessible, experienced partner comfortable in complex multi-country setups.

Despite only 3 projects, ALTERTOX has built a broad network of 43 partners across 13 countries, reflecting their involvement in major pan-European toxicology consortia. Their reach is firmly European with no apparent geographic concentration beyond their Belgian base.

What sets them apart

ALTERTOX sits at the intersection of alternative toxicology and commercial application — a private SME in a field dominated by universities and public research institutes. Their name itself signals their mission: alternatives to animal toxicology testing. For consortium builders, they offer practical, business-oriented expertise in animal-free testing methods, bridging the gap between academic research and regulatory implementation.

Highlights from their portfolio

• PrecisionTox
  Largest funding (EUR 993K) and most ambitious scope — building a complete framework of New Approach Methodologies using phylogenetic and systems toxicology across species.
• ONTOX
  Combines AI and ontology for toxicity prediction — represents the computational frontier of animal-free chemical safety assessment.
• PANORAMIX
  Addresses the complex real-world problem of chemical mixtures risk assessment, directly relevant to EU citizen health protection policy.